Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Encephalitis D004660 15 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Contracture D003286 3 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Blister D001768 16 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Ileal Diseases D007077 3 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Gliosis D005911 6 associated lipids
Neuralgia D009437 28 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Amnesia D000647 12 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Liver Failure D017093 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Helicobacter Infections D016481 21 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Mucositis D052016 7 associated lipids
Ileitis D007079 2 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ambrosio G and Tritto I Reperfusion injury: experimental evidence and clinical implications. 1999 Am. Heart J. pmid:10426862
Maruyama M et al. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. 1990 Am. Heart J. pmid:2389687
Schwinger RH et al. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. 1992 Am. Heart J. pmid:1322030
Kwiterovich PO The antiatherogenic role of high-density lipoprotein cholesterol. 1998 Am. J. Cardiol. pmid:9819099
Madsen NJ et al. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents. 2007 Am. J. Cardiol. pmid:17697836
Shohet RV et al. Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis. 1999 Am. J. Cardiol. pmid:10073795
Zhang C et al. The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats. 2004 Am. J. Chin. Med. pmid:15154282
Prescott SM What are the effects of dietary fatty acid modification on platelet eicosanoid metabolism, platelet-activating factor, and platelet function? How might these metabolic alterations influence thrombosis? 1992 Am. J. Clin. Nutr. pmid:1414987
Sandler RM et al. Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. 1985 Am. J. Clin. Pathol. pmid:4003343
Sandberg-Gertzén H An open trial of Cedemin, a Gingko biloba extract with PAF-antagonistic effects for ulcerative colitis. 1993 Am. J. Gastroenterol. pmid:8470656
Braquet P Cedemin, a Ginkgo biloba extract, should not be considered as a PAF antagonist. 1993 Am. J. Gastroenterol. pmid:8110248
Verhoef G and Boogaerts M Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. 1991 Am. J. Hematol. pmid:1672790
Rao AK et al. Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. 1984 Am. J. Hematol. pmid:6431801
Issekutz AC and Ripley M The effect of intravascular neutrophil chemotactic factors on blood neutrophil and platelet kinetics. 1986 Am. J. Hematol. pmid:2934975
Radhika V et al. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants. 1996 Am. J. Hematol. pmid:8756080
Lo GK et al. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? 2007 Am. J. Hematol. pmid:17722079
Marx G et al. Nutritional zinc increases platelet reactivity. 1991 Am. J. Hematol. pmid:1951315
Pelczar-Wissner CJ et al. Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. 1984 Am. J. Hematol. pmid:6720685
Yoshida H et al. Activity of platelet-activating factor acetylhydrolase exists in red cell membrane. 1992 Am. J. Hematol. pmid:1566749
Greinacher A Too many hits in HIT? 2007 Am. J. Hematol. pmid:17729242
Hollister AS et al. Humoral factor, intraplatelet calcium, and hypertension. 1992 Am. J. Hypertens. pmid:1632935
Macconi D et al. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. 1992 Am. J. Kidney Dis. pmid:1562019
Tetta C et al. Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. 1997 Am. J. Kidney Dis. pmid:9372980
Tanaka R et al. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. 1999 Am. J. Kidney Dis. pmid:10430976
Hall AV et al. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed. 1993 Am. J. Kidney Dis. pmid:8352261
Gallego MJ et al. Cyclosporine enhances leukocyte adhesion to vascular endothelium under physiologic flow conditions. 1996 Am. J. Kidney Dis. pmid:8712218
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870
Barnes PJ Inflammatory mechanisms and nocturnal asthma. 1988 Am. J. Med. pmid:3041827
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Wright NR et al. Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction. 2016 Am. J. Med. pmid:26524710
Ganong BR Roles of lipid turnover in transmembrane signal transduction. 1991 Am. J. Med. Sci. pmid:1661067
Muirhead EE et al. Biologic contrasts between medullipin I and vasoactive glyceryl compounds. 1989 Am. J. Med. Sci. pmid:2764021
Gaylord MS et al. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia. 1996 Am. J. Med. Sci. pmid:8853062
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Perico N and Remuzzi G Role of platelet-activating factor in renal immune injury and proteinuria. 1990 Am. J. Nephrol. pmid:2256482
Kees-Folts D and Diamond JR Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. 1993 Am. J. Nephrol. pmid:8116689
Camussi G et al. Platelet-activating factor in renal diseases. 1989 Am. J. Nephrol. pmid:2646923
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Tabor BL et al. Platelet-activating factor antagonists decrease lung protein leak in preterm ventilated rabbits. 1992 Am. J. Obstet. Gynecol. pmid:1530043
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Benedetto C et al. Reduced serum inhibition of platelet-activating factor activity in preeclampsia. 1989 Am. J. Obstet. Gynecol. pmid:2912073
Morris C et al. Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. 1992 Am. J. Obstet. Gynecol. pmid:1566774
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Matorras R and Pijoan JI The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. 2002 Am. J. Obstet. Gynecol. pmid:11904634
Hoffman DR et al. Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. 1990 Am. J. Obstet. Gynecol. pmid:2309839
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Minhas BS et al. Effects of platelet activating factor on mouse oocyte fertilization in vitro. 1989 Am. J. Obstet. Gynecol. pmid:2603931
Silver RK et al. Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production. 1991 Am. J. Obstet. Gynecol. pmid:1750472
Minhas BS Platelet-activating factor treatment of human spermatozoa enhances fertilization potential. 1993 Am. J. Obstet. Gynecol. pmid:8475981
Sueoka K et al. Platelet activating factor-induced early pregnancy factor activity from the perfused rabbit ovary and oviduct. 1988 Am. J. Obstet. Gynecol. pmid:3207134